Ongericimab

• Description :

  Ongericimab (JS002) is a humanized anti-PCSK9 monoclonal antibody. Ongericimab has lipid-lowering efficacy. Ongericimab can be used in research of hypercholesteremia and hyperlipidemia[1].

• Product Name Alternative :

  JS002

• UNSPSC :

  12352203

• Target :

  PCSK9

• Type :

  Inhibitory Antibodies

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Metabolism-sugar/lipid metabolism

• Field of Research :

  Metabolic Disease; Cardiovascular Disease

• Assay Protocol :

  https://www.medchemexpress.com/ongericimab.html

• Purity :

  99.0

• Solubility :

  10 mM in DMSO

• Smiles :

  [Ongericimab]

• Molecular Weight :

  (143.02 kDa)

• References & Citations :

  [1]Min C, et, al. Application of PCSK9 inhibitor in preparation of product for promoting hair growth. CN113876955.

• Shipping Conditions :

  Dry Ice

• Storage Conditions :

  Store at -80°C for 2 years

• Scientific Category :

  Inhibitory Antibodies

• Clinical Information :

  Phase 3

• CAS Number :

  [2145096-91-7]